These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 25693942)

  • 1. A systematic review and meta-analysis of runt-related transcription factor 3 gene promoter hypermethylation and risk of gastric cancer.
    Xia Y; Zhang M; Zhang X; Liu X
    J Cancer Res Ther; 2014 Dec; 10 Suppl():310-3. PubMed ID: 25693942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between runt-related transcription factor 3 gene promoter methylation and gastric cancer: A meta-analysis.
    Liu X; Wang L; Guo Y
    J Cancer Res Ther; 2016 Oct; 12(Supplement):50-53. PubMed ID: 27721253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationship between Runx3 gene expression and its DNA methylation in gastric cancer].
    Gao N; Chen WC; Cen JN
    Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):361-4. PubMed ID: 18953836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between RUNX3 promoter methylation and gastric cancer: a meta-analysis.
    Fan XY; Hu XL; Han TM; Wang NN; Zhu YM; Hu W; Ma ZH; Zhang CJ; Xu X; Ye ZY; Han CM; Pan WS
    BMC Gastroenterol; 2011 Aug; 11():92. PubMed ID: 21867527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Runt-related Transcription Factor 3 Promoter Hypermethylation and Gastric Cancer Risk: A Meta-analysis.
    Lina M; Changan W; Qing Z
    Open Life Sci; 2018 Jan; 13():64-70. PubMed ID: 33817069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-specific Hypermethylation of RUNX3 Predicts Poor Prognosis in Gastric Cancer.
    Wang N; Sui F; Ma J; Su X; Liu J; Yao D; Shi B; Hou P; Yang Q
    Arch Med Res; 2016 May; 47(4):285-92. PubMed ID: 27664488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
    Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
    Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent loss of RUNX3 expression by promoter hypermethylation in gastric carcinoma.
    Oshimo Y; Oue N; Mitani Y; Nakayama H; Kitadai Y; Yoshida K; Ito Y; Chayama K; Yasui W
    Pathobiology; 2004; 71(3):137-43. PubMed ID: 15051926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Promoter methylation and expression of Runx3 gene in gastric cancer].
    Li LY; Li JK; Shen Y; Yu L; Zhang JH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jul; 11(4):379-82. PubMed ID: 18636364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RUNX3 Promoter Methylation Is Associated with Hepatocellular Carcinoma Risk: A Meta-Analysis.
    Zhang X; He H; Zhang X; Guo W; Wang Y
    Cancer Invest; 2015 Apr; 33(4):121-5. PubMed ID: 25664646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer.
    Chen W; Gao N; Shen Y; Cen JN
    J Gastroenterol Hepatol; 2010 Apr; 25(4):823-31. PubMed ID: 20492341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stepwise cumulation of RUNX3 methylation mediated by Helicobacter pylori infection contributes to gastric carcinoma progression.
    Lu XX; Yu JL; Ying LS; Han J; Wang S; Yu QM; Wang XB; Fang XH; Ling ZQ
    Cancer; 2012 Nov; 118(22):5507-17. PubMed ID: 22576578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori infection is an independent risk factor for Runx3 methylation in gastric cancer.
    Kitajima Y; Ohtaka K; Mitsuno M; Tanaka M; Sato S; Nakafusa Y; Miyazaki K
    Oncol Rep; 2008 Jan; 19(1):197-202. PubMed ID: 18097595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypermethylation of RUNX3 but not WIF1 gene and its association with stage and nodal status of tongue cancers.
    Supic G; Kozomara R; Jovic N; Zeljic K; Magic Z
    Oral Dis; 2011 Nov; 17(8):794-800. PubMed ID: 21819494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological significance and potential drug target of RUNX3 in non-small cell lung cancer: a meta-analysis.
    Xu L; Lan H; Su Y; Li J; Wan J
    Drug Des Devel Ther; 2015; 9():2855-65. PubMed ID: 26082616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration in the expression of MGMT and RUNX3 due to non-CpG promoter methylation and their correlation with different risk factors in esophageal cancer patients.
    Saikia S; Rehman AU; Barooah P; Sarmah P; Bhattacharyya M; Deka M; Deka M; Goswami B; Husain SA; Medhi S
    Tumour Biol; 2017 May; 39(5):1010428317701630. PubMed ID: 28468586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
    Jiang Y; Tong D; Lou G; Zhang Y; Geng J
    Pathobiology; 2008; 75(4):244-51. PubMed ID: 18580070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the RUNX3 gene methylation in serum DNA from esophagus squamous cell carcinoma, gastric and colorectal adenocarcinoma patients.
    Zheng Y; Zhang Y; Huang X; Chen L
    Hepatogastroenterology; 2011; 58(112):2007-11. PubMed ID: 22234069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation of CpG methylation status of Runx3 with pathogenesis of gastric carcinoma].
    Tang GH; Sun SW; He XS
    Zhonghua Bing Li Xue Za Zhi; 2012 May; 41(5):314-9. PubMed ID: 22883670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationship between promoter methylation of Syk and Runx3 genes and postoperative recurrence and metastasis in gastric carcinoma].
    Hong H; Zhou K; Fu P; Huang Q; Wang J; Yuan X; Li J
    Zhonghua Zhong Liu Za Zhi; 2014 May; 36(5):341-5. PubMed ID: 25030588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.